vix.ing · top · new · best · stats · spec

Multi-Modal Oral Cancer Detection Using Weighted Ensemble Convolutional Neural Networks

2025/10/04 by George, Ajo Babu, George, Sreehari J R Ajo Babu, J R Sreehari +1
Computer Science · Medicine · #AI in cancer detection #Artificial Intelligence (cs.AI) #Computer Vision and Pattern Recognition (cs.CV) #Cutaneous Melanoma Detection and Management #FOS: Computer and information sciences #Head and Neck Cancer Studies

paper · pdf · doi:10.48550/arxiv.2510.03878

openalex publication_date 2025/10/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Abstract

Aims Late diagnosis of Oral Squamous Cell Carcinoma (OSCC) contributes significantly to its high global mortality rate, with over 50% of cases detected at advanced stages and a 5-year survival rate below 50% according to WHO statistics. This study aims to improve early detection of OSCC by developing a multimodal deep learning framework that integrates clinical, radiological, and histopathological images using a weighted ensemble of DenseNet-121 convolutional neural networks (CNNs). Material and Methods A retrospective study was conducted using publicly available datasets representing three distinct medical imaging modalities. Each modality-specific dataset was used to train a DenseNet-121 CNN via transfer learning. Augmentation and modality-specific preprocessing were applied to increase robustness. Predictions were fused using a validation-weighted ensemble strategy. Evaluation was performed using accuracy, precision, recall, F1-score. Results High validation accuracy was achieved for radiological (100%) and histopathological (95.12%) modalities, with clinical images performing lower (63.10%) due to visual heterogeneity. The ensemble model demonstrated improved diagnostic robustness with an overall accuracy of 84.58% on a multimodal validation dataset of 55 samples. Conclusion The multimodal ensemble framework bridges gaps in the current diagnostic workflow by offering a non-invasive, AI-assisted triage tool that enhances early identification of high-risk lesions. It supports clinicians in decision-making, aligning with global oncology guidelines to reduce diagnostic delays and improve patient outcomes.

Citations

Related